IFU
VRTX icon

iSAM Funds (UK)’s Vertex Pharmaceuticals VRTX Stock Holding History

iSAM Funds (UK)’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Sell
750
-2,471
-77% -$1.15M 0.17% 186
2025
Q4 		$1.46M Buy
3,221
+1,971
+158% +$850K 0.53% 59
2025
Q3 		$490K Buy
+1,250
New +$522K 0.1% 276
2024
Q4 		– Sell
-1,051
Closed -$489K – 418
2024
Q3 		$489K Buy
+1,051
New +$505K 0.28% 142
2024
Q2 		– Sell
-2,015
Closed -$842K – 378
2024
Q1 		$842K Buy
+2,015
New +$852K 0.48% 75

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

iSAM Funds (UK)'s VRTX Position: Q1 2026 in Review

iSAM Funds (UK) reduced its Vertex Pharmaceuticals (VRTX) stake by 77% in Q1 2026, selling an estimated $1.15M and leaving 750 shares worth $335K. The position accounts for 0.17% of the portfolio, ranked #186.

iSAM Funds (UK) first reported a position in VRTX in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.46M in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • iSAM Funds (UK) held 750 shares of Vertex Pharmaceuticals worth $335K as of Q1 2026.
  • iSAM Funds (UK) sold 2,471 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.15M.
  • Vertex Pharmaceuticals made up 0.17% of iSAM Funds (UK)'s portfolio in Q1 2026, its #186 holding.
  • iSAM Funds (UK) first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • iSAM Funds (UK)'s Vertex Pharmaceuticals position peaked at $1.46M in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on iSAM Funds (UK)'s 13F filing for Q1 2026, filed 13 May 2026.